| abstract |
The present invention relates to compounds of formula I, wherein Ht, G, R 10 , R 30 , R 40 , R 50 and R 60 have the meanings specified in the claims, which are valuable pharmaceutically active compounds. The compounds are inhibitors of the protease cathepsin A and are useful in the treatment of diseases such as atherosclerosis, heart failure, kidney disease, liver disease or inflammatory diseases. Furthermore, the invention relates to processes for the preparation of compounds of formula I, their use and pharmaceutical compositions comprising them. |